Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: A retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program

► We assessed effects of rosuvastatin on risk of developing renal impairment/failure. ► Participants were in rosuvastatin clinical development program. ► No effect on risk in patients without advanced, pre-existing renal disease.